CIAM
TXG icon

Caitong International Asset Management’s 10x Genomics TXG Stock Holding History

Caitong International Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-883
Closed -$14.4K – 3053
2025
Q4 		$14.4K Sell
883
-483
-35% -$7.3K ﹤0.01% 1068
2025
Q3 		$16K Buy
1,366
+1,026
+302% +$13.4K 0.01% 824
2025
Q2 		$3.94K Buy
340
+335
+6,700% +$3.05K ﹤0.01% 1119
2025
Q1 		$44 Sell
5
-184
-97% -$2.32K ﹤0.01% 2044
2024
Q4 		$2.71K Buy
+189
New +$2.98K ﹤0.01% 1131

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caitong International Asset Management's TXG Position: Q1 2026 in Review

Caitong International Asset Management sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 883 shares — an estimated $14.4K sold.

Caitong International Asset Management first reported a position in TXG in Q4 2024 and held it in 5 quarters. The position peaked at $16K in Q3 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Caitong International Asset Management reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 883 10x Genomics shares in Q1 2026, an estimated $14.4K.
  • Caitong International Asset Management first reported a position in 10x Genomics in Q4 2024 and held it in 5 quarters.
  • Caitong International Asset Management's 10x Genomics position peaked at $16K in Q3 2025.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.